| __timestamp | Iovance Biotherapeutics, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 406114000 |
| Thursday, January 1, 2015 | 12390000 | 449119000 |
| Friday, January 1, 2016 | 25602000 | 502892000 |
| Sunday, January 1, 2017 | 21262000 | 544156000 |
| Monday, January 1, 2018 | 28430000 | 683530000 |
| Tuesday, January 1, 2019 | 40849000 | 736942000 |
| Wednesday, January 1, 2020 | 60210000 | 854233000 |
| Friday, January 1, 2021 | 83664000 | 1451683000 |
| Saturday, January 1, 2022 | 104097000 | 1416967000 |
| Sunday, January 1, 2023 | 106916000 | 1343105000 |
Infusing magic into the data realm
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Jazz Pharmaceuticals plc and Iovance Biotherapeutics, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, Jazz Pharmaceuticals consistently reported higher SG&A expenses, peaking at approximately $1.45 billion in 2021. This represents a staggering 257% increase from their 2014 expenses. In contrast, Iovance Biotherapeutics, while starting with significantly lower expenses, saw a more dramatic rise, with a 1,042% increase over the same period, reaching around $107 million in 2023.
This data highlights the contrasting strategies of these companies. Jazz's larger scale and broader market presence may justify its higher expenses, while Iovance's rapid growth suggests aggressive expansion efforts. Understanding these trends provides valuable insights into the financial strategies of leading biopharma companies.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
SG&A Efficiency Analysis: Comparing Viatris Inc. and Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc.
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: ACADIA Pharmaceuticals Inc. vs Iovance Biotherapeutics, Inc.